Item request has been placed!

Item request cannot be made.

Processing Request

نتائج البحث

Display Settings

النتائج لكل صفحة: 10

Sort By: Relevance

Filter

فلترة النتائج

إعادة تعيين خيارات الفبترة

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Myeloproliferative Neoplasms: New Translational Therapies.

Authors : Mascarenhas, John¹ ; Hoffman, Ronald¹

Source: Mount Sinai Journal of Medicine. Nov/Dec2010, Vol. 77 Issue 6, p667-683. 17p. 2 Charts.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Deletions of the transcription factor Ikaros in myeloproliferative neoplasms.

Authors : Jäger, R.¹; Gisslinger, H.²; Passamonti, F.³

Source: Leukemia (08876924). Jul2010, Vol. 24 Issue 7, p1290-1298. 9p. 1 Diagram, 3 Charts, 3 Graphs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Treatment options for hydroxyurea-refractory disease complications in myeloproliferative neoplasms: JAK2 inhibitors, radiotherapy, splenectomy and transjugular intrahepatic portosystemic shunt.

Authors : Mishchenko, Elena¹; Tefferi, Ayalew²

Source: European Journal of Haematology. Sep2010, Vol. 85 Issue 3, p192-199. 8p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

JAK2 Exon 14 Deletion in Patients with Chronic Myeloproliferative Neoplasms.

Authors : Wanlong Ma; Kantarjian, Hagop; Xi Zhang

Source: PLoS ONE. 2010, Vol. 5 Issue 8, p1-7. 7p. 3 Diagrams, 1 Chart, 2 Graphs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

The Role of CD56, HBME-1, and p63 in Follicular Neoplasms of the Thyroid.

Authors : Etem, Hülya; Özekıncı, Selver; Mızrak, Bülent

Source: Turkish Journal of Pathology. 2010, Vol. 26 Issue 3, p238-242. 5p. 3 Color Photographs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Effective targeting of STAT5-mediated survival in myeloproliferative neoplasms using ABT-737 combined with rapamycin.

Authors : Li, G.¹; Miskimen, K. L.¹; Wang, Z.²

Source: Leukemia (08876924). Aug2010, Vol. 24 Issue 8, p1397-1405. 9p. 1 Black and White Photograph, 1 Diagram, 5 Graphs.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1.

Authors : Tefferi, A.¹

Source: Leukemia (08876924). Jun2010, Vol. 24 Issue 6, p1128-1138. 11p. 2 Diagrams, 1 Chart.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

PIM-1 kinase expression in adipocytic neoplasms: diagnostic and biological implications.

Authors : Min En Nga¹; Nu Nu Ma Swe¹; Kang Ting Chen²

Source: International Journal of Experimental Pathology. Feb2010, Vol. 91 Issue 1, p34-43. 10p. 4 Color Photographs, 3 Charts, 1 Graph.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Evaluation of JAK2 V617F Mutation and Correlations of This Mutation with Clinical and Laboratory Findings in Patients with Myeloproliferative Neoplasms.

Authors : Nadali, Fatemeh; Ferdowsi, Shirin; Einollahi, Nahid

Source: Journal of Isfahan Medical School. May2010, Vol. 28 Issue 105, p1-11. 11p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.

Authors : HALL, J.¹; FOUCAR, K.¹

Source: International Journal of Laboratory Hematology. Dec2010, Vol. 32 Issue 6p2, p559-571. 13p. 2 Color Photographs, 3 Charts.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Myeloproliferative Neoplasms: New Translational Therapies.

Deletions of the transcription factor Ikaros in myeloproliferative neoplasms.

Treatment options for hydroxyurea-refractory disease complications in myeloproliferative neoplasms: JAK2 inhibitors, radiotherapy, splenectomy and transjugular intrahepatic portosystemic shunt.

JAK2 Exon 14 Deletion in Patients with Chronic Myeloproliferative Neoplasms.

The Role of CD56, HBME-1, and p63 in Follicular Neoplasms of the Thyroid.

Effective targeting of STAT5-mediated survival in myeloproliferative neoplasms using ABT-737 combined with rapamycin.

Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1.

PIM-1 kinase expression in adipocytic neoplasms: diagnostic and biological implications.

Evaluation of JAK2 V617F Mutation and Correlations of This Mutation with Clinical and Laboratory Findings in Patients with Myeloproliferative Neoplasms.

Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.

اتصل بنا

اتبع